Can it move?
Policy and site-of-service eligibility.
Compare surgical settings without losing sight of patient safety or operational feasibility.
This four-week paid assessment compares reimbursement, procedure mix, costs, and capacity across surgical settings. We model alternative scenarios, identify staffing and operational constraints, and deliver a practical action plan. Estimates are not guaranteed savings.
Independent or PE-backed orthopedic enterprises, orthopedic MSOs and platforms, physician-owned ASCs, and physician enterprises participating in hospital-ASC joint ventures.
CEO, president, CFO, COO, ASC executive, and physician board.
Orthopedic medical director, physician president, and high-volume surgeons.
Orthopedic leaders are being asked to make increasingly consequential site-of-care decisions as surgical eligibility, payer policies, ASC capacity, physician practice patterns, and economics evolve at different speeds.
The central question is not simply whether a procedure can move to a lower-acuity setting. Leadership must determine whether a specific patient cohort should move, whether the payer will support that setting, whether the organization can execute safely and efficiently, and whether the economics justify the change.
Site-of-care decisions may be distributed across clinical judgment, reimbursement analysis, payer policy, ASC operations, physician preference, and finance.
Leadership sees which procedure cohorts warrant action, which should remain in the current setting, what the modeled opportunity is, what assumptions drive the estimate, and which payer, operational, or clinical constraint must be resolved before acting.
Looking for quick answers on CY2027 OPPS/ASC proposed rules, CPT eligibility, or setting reimbursement direction? Run your procedure and setting questions in our free interactive assistant. When you need organization-specific claims analysis, facility contribution modeling, and physician alignment, request the full Blueprint.
See What Changes — Jan 1, CY2027 (free calculator)Policy and site-of-service eligibility.
Clinical appropriateness and patient-selection considerations.
Coverage, authorization, network, and reimbursement feasibility.
Capacity, anesthesia, staffing, equipment, implants, recovery, transfer, and workflow readiness.
Site-specific reimbursement, contribution economics, incremental operating requirements, and addressable volume.
Physician alignment, practice-pattern variation, and execution readiness.
Procedure-level view of current site-of-care distribution, potential site alternatives, external leakage, and meaningful physician and practice-pattern variation.
Compare current and alternative settings for each selected procedure. Scenarios include volume, Medicare and one selected commercial payer, reimbursement, facility contribution, implant costs, operating needs, and ASC capacity where data are available. Assumptions are labeled separately from observed client data; estimates are not guaranteed results.
Patient-selection considerations, payer friction, ASC capacity, anesthesia, staffing, equipment, implants, recovery capability, scheduling, transfer arrangements, and workflow constraints. The purpose is not to maximize migration; it is to identify where migration is appropriate, where it is not, and what must be true before execution.
Each procedure cohort receives one of five recommended actions, so leadership sees a decision rather than a list of findings.
Evidence supports greater use of the alternative site of care.
The current pathway remains appropriate.
The opportunity appears attractive, but an operational constraint prevents execution.
Clinical and operational conditions support change, but payer economics or contract terms do not.
Evidence is insufficient for a confident decision.
Strong clinical, financial, payer, and operational evidence.
Direction supported, but assumptions or data gaps remain.
Insufficient evidence for a management decision without further validation.
CPT/HCPCS, procedure volume, surgeon, payer, current site of service, reimbursement/allowed amount, facility cost or contribution margin when available, authorization/denial information when available, ASC utilization/capacity, and major implant/device costs when relevant.
Unavailable data are treated as explicit assumptions and lower confidence rather than being presented as observed results.
The analysis supports executive and physician decision-making and does not replace patient-specific clinical judgment.
Includes one ASC or defined site-of-care network, one orthopedic service line, 5–10 procedures, Medicare plus one selected commercial payer, all four executive assets, an executive readout, and a 90-day action plan.
Multi-site, multi-market, and portfolio engagements are scoped separately.
Most site-of-care analyses stop at eligibility, reimbursement, or operational planning. ClinEfficiency Pro connects the full decision chain: policy eligibility, patient appropriateness, payer feasibility, operational readiness, site-of-care economics, and physician adoption.
The outcome is not another report. It is a defensible executive decision about where surgical care should occur, what the decision is worth, and what must change before the organization acts.
The initial 30-minute conversation is exploratory, not the assessment itself. Bring one service line, one site-of-care question, and 3–5 procedures of interest. We determine whether the scoped paid Blueprint is appropriate and agree the scope and fee before work begins.
Not ready for a full executive review? Start with the free CEP Surgical Site Economics tool.
Open the free tool